0001209191-23-018952.txt : 20230315 0001209191-23-018952.hdr.sgml : 20230315 20230315172008 ACCESSION NUMBER: 0001209191-23-018952 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230314 FILED AS OF DATE: 20230315 DATE AS OF CHANGE: 20230315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kidron Miriam CENTRAL INDEX KEY: 0001409232 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35813 FILM NUMBER: 23736213 MAIL ADDRESS: STREET 1: 2 ELZA STREET CITY: JERUSALEM STATE: L3 ZIP: 93706 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORAMED PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001176309 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980376008 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 646-844-1164 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: Integrated Security Technologies, Inc. DATE OF NAME CHANGE: 20040614 FORMER COMPANY: FORMER CONFORMED NAME: IGUANA VENTURES LTD DATE OF NAME CHANGE: 20020625 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-14 0 0001176309 ORAMED PHARMACEUTICALS INC. ORMP 0001409232 Kidron Miriam 2 ELZA STREET JERUSALEM L3 93706 ISRAEL 1 1 0 0 Chief Scientific Officer Common Stock 2023-03-14 4 S 0 100000 2.01 D 201666 D These shares were sold to a company owned solely by Nadav Kidron, a director and the president and chief executive officer of the Issuer, and the Reporting Person used the proceeds in connection with a personal tax payment. /s/ Miriam Kidron 2023-03-15